{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:08:25Z","timestamp":1774094905627,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10620-024-08368-y","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:02:42Z","timestamp":1711105362000},"page":"1863-1871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Sclerosing Cholangitis: Gender Effects in Valencia\u2019s Low-Prevalence Region"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-1377","authenticated-orcid":false,"given":"Alejandro","family":"M\u00ednguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mont\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Palau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"For\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concha","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Girona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Di Maira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"8368_CR1","first-page":"4517e9","volume":"118","author":"JE Berdal","year":"1998","unstructured":"Berdal JE, Ebbesen J, Rydning A. [Incidence and prevalence of autoimmune liver diseases] Insidens og prevalens av autoimmune leverlidelser. Tidsskr Nor Laegeforen 1998;118:4517e9.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"8368_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"9","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet 2013;9:1587\u20131599. https:\/\/doi.org\/10.1016\/S0140-6736(13)60096-3.","journal-title":"Lancet"},{"key":"8368_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181\u20131188. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025.","journal-title":"Journal of Hepatology"},{"key":"8368_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5009\/gnl16510","volume":"15","author":"C Palmela","year":"2018","unstructured":"Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features. Gut Liver 2018;15:17\u201329. https:\/\/doi.org\/10.5009\/gnl16510.","journal-title":"Gut Liver"},{"key":"8368_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu JZ, Hov JR, Folseraas T et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013;45:670\u2013675. https:\/\/doi.org\/10.1038\/ng.2616.","journal-title":"Nature Genetics"},{"key":"8368_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"E Loftus","year":"2005","unstructured":"Loftus E, Harewood G, Loftus C et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91\u201396. https:\/\/doi.org\/10.1136\/gut.2004.046615.","journal-title":"Gut."},{"key":"8368_CR7","doi-asserted-by":"publisher","first-page":"175628482311594","DOI":"10.1177\/17562848231159452","volume":"5","author":"B Bressler","year":"2023","unstructured":"Bressler B. Is there an optimal sequence of biologic therapies for inflammatory bowel disease? Therap Adv Gastroenterol. 2023;5:17562848231159452. https:\/\/doi.org\/10.1177\/17562848231159452.","journal-title":"Therap Adv Gastroenterol."},{"key":"8368_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045\u20132055. https:\/\/doi.org\/10.1002\/hep.26565.","journal-title":"Hepatology"},{"key":"8368_CR9","doi-asserted-by":"publisher","first-page":"330e40","DOI":"10.1002\/lt.21679","volume":"15","author":"E Alabraba","year":"2009","unstructured":"Alabraba E, Nightingale P, Gunson B et al. A reevaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009;15:330e40. https:\/\/doi.org\/10.1002\/lt.21679.","journal-title":"Liver Transpl"},{"key":"8368_CR10","doi-asserted-by":"publisher","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep 2016;6:25906. https:\/\/doi.org\/10.1038\/srep25906.","journal-title":"Sci Rep."},{"key":"8368_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 2013;144:560\u2013569. https:\/\/doi.org\/10.1053\/j.gastro.2012.12.005.","journal-title":"Gastroenterology"},{"key":"8368_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","volume":"48","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008;48:140\u2013147. https:\/\/doi.org\/10.1016\/j.jhep.2007.08.013.","journal-title":"J Hepatol"},{"key":"8368_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/cld.797","volume":"14","author":"D Gleeson","year":"2019","unstructured":"Gleeson D. Long-term outcomes of autoimmune hepatitis. Clin Liver Dis (Hoboken) 2019;14:24\u201328. https:\/\/doi.org\/10.1002\/cld.797.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"8368_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00281-018-0715-8","volume":"41","author":"D Schwinge","year":"2019","unstructured":"Schwinge D, Schramm C. Sex-related factors in autoimmune liver diseases. SeminImmunopathol 2019;41:165\u2013175. https:\/\/doi.org\/10.1007\/s00281-018-0715-8.","journal-title":"SeminImmunopathol"},{"key":"8368_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/apt.15060","volume":"49","author":"MH Harms","year":"2019","unstructured":"Harms MH, Janssen QP, Adam R et al. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Aliment PharmacolTher 2019;49:285\u2013295. https:\/\/doi.org\/10.1111\/apt.15060.","journal-title":"Aliment PharmacolTher"},{"key":"8368_CR16","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller TJ, Trivedi PJ, Bergquist A et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 2017;152:1975-1984.e8. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038.","journal-title":"Gastroenterology"},{"key":"8368_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on sclerosing cholangitis. J Hepatol 2022;77:761\u2013806. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.011.","journal-title":"J Hepatol."},{"key":"8368_CR18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.21685","volume":"45","author":"E Bj\u00f6rnsson","year":"2007","unstructured":"Bj\u00f6rnsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007;45:1547\u20131554. https:\/\/doi.org\/10.1002\/hep.21685.","journal-title":"Hepatology"},{"key":"8368_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/hep.21405","volume":"44","author":"R Abdalian","year":"2006","unstructured":"Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology 2006;44:1063\u20131074. https:\/\/doi.org\/10.1002\/hep.21405.","journal-title":"Hepatology"},{"key":"8368_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000440823","volume":"33","author":"CY Ponsioen","year":"2015","unstructured":"Ponsioen CY. Diagnosis, differential diagnosis, and epidemiology of primary sclerosing cholangitis. Dig Dis 2015;33:134\u2013139. https:\/\/doi.org\/10.1159\/000440823.","journal-title":"Dig Dis"},{"key":"8368_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-230X-11-83","volume":"18","author":"E Toy","year":"2011","unstructured":"Toy E, Balasubramanian S, Selmi C, Li C, Bowlus CL. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol 2011;18:83. https:\/\/doi.org\/10.1186\/1471-230X-11-83.","journal-title":"BMC Gastroenterol"},{"key":"8368_CR22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","volume":"125","author":"K Bambha","year":"2003","unstructured":"Bambha K, Kim WR, Talwalkar J et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364\u20131369. https:\/\/doi.org\/10.1016\/j.gastro.2003.07.011.","journal-title":"Gastroenterology"},{"key":"8368_CR23","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1038\/ctg.2015.33","volume":"27","author":"SN Sclair","year":"2015","unstructured":"Sclair SN, Little E, Levy E. Current concepts in primary biliary cirrhosis and primary sclerosing cholangitis. Clin Transl Gastroenterol 2015;27:e109. https:\/\/doi.org\/10.1038\/ctg.2015.33.","journal-title":"Clin Transl Gastroenterol"},{"key":"8368_CR24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/hep.24247","volume":"53","author":"NA Molodecky","year":"2011","unstructured":"Molodecky NA, Kareemi H, Parab R et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 2011;53:1590\u20131599. https:\/\/doi.org\/10.1002\/hep.24247.","journal-title":"Hepatology"},{"key":"8368_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","volume":"48","author":"TR Card","year":"2008","unstructured":"Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 2008;48:939\u2013944. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.017.","journal-title":"J Hepatol"},{"key":"8368_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.23678","volume":"52","author":"B Lindkvist","year":"2010","unstructured":"Lindkvist B, de Valle MB, Gullberg B, Bj\u00f6rnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010;52:571\u2013577. https:\/\/doi.org\/10.1002\/hep.23678.","journal-title":"Hepatology"},{"key":"8368_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","volume":"101","author":"CN Bernstein","year":"2006","unstructured":"Bernstein CN, Wajda A, Svenson LW et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559\u20131568. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00603.x.","journal-title":"Am J Gastroenterol"},{"key":"8368_CR28","first-page":"5","volume":"30","author":"T Kitahora","year":"1995","unstructured":"Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. J Gastroenterol 1995;30:5\u20138.","journal-title":"J Gastroenterol"},{"key":"8368_CR29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/TP.0000000000003542","volume":"105","author":"M Berenguer","year":"2021","unstructured":"Berenguer M, Di Maira T, Baumann U et al. Characteristics, trends and outcomes of liver transplantation for primary sclerosing cholangitis in female vs male patients: an analysis from the European Liver Transplant Registry. Transplantation 2021;105:2255\u20132262. https:\/\/doi.org\/10.1097\/TP.0000000000003542.","journal-title":"Transplantation."},{"key":"8368_CR30","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/lt.21916","volume":"15","author":"JC Duclos-Vallee","year":"2009","unstructured":"Duclos-Vallee JC, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl 2009;15:S25-34. https:\/\/doi.org\/10.1002\/lt.21916.","journal-title":"Liver Transpl"},{"key":"8368_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","volume":"31","author":"T Visseren","year":"2017","unstructured":"Visseren T, Murad SD. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation. Best Pract Res Clin Gastroenterol 2017;31:187\u2013198. https:\/\/doi.org\/10.1016\/j.bpg.2017.04.004.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"8368_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/003655202760373434","volume":"37","author":"KM Boberg","year":"2002","unstructured":"Boberg KM, Bergquist A, Mitchell S et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002;37:1205\u20131211. https:\/\/doi.org\/10.1080\/003655202760373434.","journal-title":"Scand J Gastroenterol"},{"key":"8368_CR33","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","volume":"52","author":"J Fevery","year":"2007","unstructured":"Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci 2007;52:3123\u20133135. https:\/\/doi.org\/10.1007\/s10620-006-9681-4.","journal-title":"Dig Dis Sci"},{"key":"8368_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","volume":"102","author":"JJ Tischendorf","year":"2007","unstructured":"Tischendorf JJ, Hecker H, Kr\u00fcger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007;102:107\u2013114. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00872.x.","journal-title":"Am J Gastroenterol"},{"key":"8368_CR35","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710\u20131717. https:\/\/doi.org\/10.1016\/0016-5085(91)90673-9.","journal-title":"Gastroenterology"},{"key":"8368_CR36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/gut.38.4.610","volume":"38","author":"U Broome","year":"1996","unstructured":"Broome U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610\u2013615. https:\/\/doi.org\/10.1136\/gut.38.4.610.","journal-title":"Gut"},{"key":"8368_CR37","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol 2017;67:1298\u20131323. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.022.","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08368-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08368-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08368-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T16:11:25Z","timestamp":1715875885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08368-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["8368"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08368-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been reviewed and approved by the Medicine Research Ethics Committee (CEIM) of H. U. P. La Fe (registration number: 2020-109-1: January 28, 2020). This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}